The Maryland Aggregate Pathology Index: A deceased donor kidney biopsy scoring system for predicting graft failure

American Journal of Transplantation

Volumn 8, Issue 11, 2008, Pages 2316-2324

  Munivenkatappa, R B ^a   Schweitzer, E J ^a   Papadimitriou, J C ^a   Drachenberg, C B ^a   Thom, K A ^a   Perencevich, E N ^a   Haririan, A ^a   Rasetto, F ^a   Cooper, M ^a   Campos, L ^a   Barth, R N ^a   Bartlett, S T ^a   Philosophe, B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Deceased donor kidneys; Graft survival; Scoring system

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; GLOMERULOSCLEROSIS; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HYALINE DEGENERATION; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; BIOPSY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MARYLAND; MIDDLE AGED; TREATMENT OUTCOME;

EID: 53749087549     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02370.x     Document Type: Article

References (42)

1. Lee CM, Scandling JD, Shen GK, Salvatierra O, Dafoe DC, Alfrey EJ. The kidneys that nobody wanted: Support for the utilization of expanded criteria donors. Transplantation 1996 62 : 1832 1841.
2. Hariharan S, McBride MA, Bennett LE, Cohen EP. Risk factors for renal allograft survival from older cadaver donors. Transplantation 1997 64 : 1748 1754.
3. Matas AJ, Gillingham KJ, Elick BA et al. Risk factors for prolonged hospitalization after kidney transplants. Clin Transplant 1997 11 : 259 264.
4. Matas AJ, Gillingham KJ, Humar A, Dunn DL, Sutherland DE, Najarian JS. Immunologic and nonimmunologic factors: Different risks for cadaver and living donor transplantation. Transplantation 2000 69 : 54 58.
5. McLaren AJ, Jassem W, Gray DW, Fuggle SV, Welsh KI, Morris PJ. Delayed graft function: Risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 1999 13 : 266 272.
6. Morris PJ, Johnson RJ, Fuggle SV, Belger MA, Briggs JD. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999 354 : 1147 1152.
7. Ojo AO, Leichtman AB, Punch JD et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000 36 : 153 159.
8. Pfaff WW, Howard RJ, Patton PR, Adams VR, Rosen CB, Reed AI. Delayed graft function after renal transplantation. Transplantation 1998 65 : 219 223.
9. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants. Clin Transplant 1997 11 : 366 372.
10. Tullius SG, Reutzel-Selke A, Egermann F et al. Contribution of prolonged ischemia and donor age to chronic renal allograft dysfunction. J Am Soc Nephrol 2000 11 : 1317 1324.
11. Sung RS, Christensen LL, Leichtman AB et al. Determinants of discard of expanded criteria donor kidneys: Impact of biopsy and machine perfusion. Am J Transplant 2008 8 : 783 792.
12. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999 130 : 461 470.
14. Papadimitriou JC, Coale R, Farney A et al. Biopsy of the marginal kidney donor: Correlation of histology with outcome. Transplant Proc 2004 36 : 742 744.
15. Gaber LW, Moore LW, Alloway RR, Amiri MH, Vera SR, Gaber AO. Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplantation 1995 60 : 334 339.
16. Pokorna E, Vitko S, Chadimova M, Schuck O, Ekberg H. Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. Transplantation 2000 69 : 36 43.
17. Bains JC, Sandford RM, Brook NR, Hosgood SA, Lewis GR, Nicholson ML. Comparison of renal allograft fibrosis after transplantation from heart-beating and non-heart-beating donors. Br J Surg 2005 92 : 113 118.
18. Bosmans JL, Woestenburg A, Ysebaert DK et al. Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts. Transplantation 2000 69 : 2388 2394.
19. Karpinski J, Lajoie G, Cattran D et al. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. Transplantation 1999 67 : 1162 1167.
20. Leunissen KM, Bosman FT, Nieman FH et al. Amplification of the nephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney. Transplantation 1989 48 : 590 593.
21. Pokorna E, Vitko S, Chadimova M, Schuck O. Adverse effect of donor arteriolosclerosis on graft outcome after renal transplantation. Nephrol Dial Transplant 2000 15 : 705 710.
22. Rowshani AT, Scholten EM, Bemelman F et al. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. J Am Soc Nephrol 2006 17 : 305 312.
23. Taub HC, Greenstein SM, Lerner SE, Schechner R, Tellis VA. Reassessment of the value of post-vascularization biopsy performed at renal transplantation: The effects of arteriosclerosis. J Urol 1994 151 : 575 577.
24. Wang HJ, Kjellstrand CM, Cockfield SM, Solez K. On the influence of sample size on the prognostic accuracy and reproducibility of renal transplant biopsy. Nephrol Dial Transplant 1998 13 : 165 172.
25. Randhawa PS, Minervini MI, Lombardero M et al. Biopsy of marginal donor kidneys: Correlation of histologic findings with graft dysfunction. Transplantation 2000 69 : 1352 1357.
26. Kuypers DR, Chapman JR, O'Connell PJ, Allen RD, Nankivell BJ. Predictors of renal transplant histology at three months. Transplantation 1999 67 : 1222 1230.
27. Seron D, Carrera M, Grino JM et al. Relationship between donor renal interstitial surface and post-transplant function. Nephrol Dial Transplant 1993 8 : 539 543.
28. Lehtonen SR, Taskinen EI, Isoniemi HM. Histopathological findings in renal allografts at time of transplantation and correlation with onset of graft function. Apmis 1999 107 : 945 950.
29. Remuzzi G, Grinyo J, Ruggenenti P et al. Early experience with dual kidney transplantation in adults using expanded donor crit3:14 PMTransplant Group (DKG). J Am Soc Nephrol 1999 10 : 2591 2598.
30. Nyberg SL, Matas AJ, Kremers WK et al. Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant 2003 3 : 715 721.
31. Re L, Cicora F, Petroni J, Goldberg J, Rial MC, Casadei D. Comparison between clinical and histopathological scoring in cadaveric kidney transplantation and its correlation with posttransplant evolution. Transplant Proc 2006 38 : 903 904.
32. Chertow GM, Milford EL, Mackenzie HS, Brenner BM. Antigen-independent determinants of cadaveric kidney transplant failure. Jama 1996 276 : 1732 1736.
33. Pessione F, Cohen S, Durand D et al. Multivariate analysis of donor risk factors for graft survival in kidney transplantation. Transplantation 2003 75 : 361 367.
34. Port FK, Bragg-Gresham JL, Metzger RA et al. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002 74 : 1281 1286.
35. Bennett WM. Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Ther 1996 34 : 515 519.
36. Bertani T, Ferrazzi P, Schieppati A et al. Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991 40 : 243 250.
37. Davies DR, Bittmann I, Pardo J. Histopathology of calcineurin inhibitor-induced nephrotoxicity. Transplantation 2000 69 (12 Suppl SS11 SS13.
38. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: An obliterative microvascular renal injury. J Am Soc Nephrol 1991 2 (2 Suppl 1 S45 S52.
39. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003 349 : 2326 2333.
40. Pascual M, Swinford RD, Ingelfinger JR, Williams WW, Cosimi AB, Tolkoff-Rubin N. Chronic rejection and chronic cyclosporin toxicity in renal allografts. Immunol Today 1998 19 : 514 519.
41. Remuzzi G, Perico N. Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int 1995 52 (Suppl S70 S74.
42. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a 3:14 PMticenter kidney transplant trial comparing tarolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group. Transplantation 1998 66 : 1736 1740.